<?xml version="1.0" encoding="UTF-8"?>
<ref id="B28">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>X. F.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>H. L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H. J.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>X. Y.</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>Y. F.</given-names>
   </name>
   <name>
    <surname>Ji</surname>
    <given-names>X.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.</article-title>
  <source>
   <italic>Nat. Commun.</italic>
  </source>
  <volume>9</volume>:
  <issue>673</issue>. 
  <pub-id pub-id-type="doi">10.1038/s41467-018-02975-w</pub-id>
  <?supplied-pmid 29445153?>
  <pub-id pub-id-type="pmid">29445153</pub-id>
 </mixed-citation>
</ref>
